Noxy Labs Sustanon Lab Test Results

Anabolic Lab
August 15, 2024

Summary

Sustanon 350 mg/ml, manufactured by Noxy Labs, underwent independent testing to verify its composition and potency. The sample, identified as batch 15TMX1, was submitted and funded by Noxy Labs for analysis by Janoshik Analytical, a laboratory specializing in anabolic steroid testing. The analysis confirmed a total measured concentration of 350.57 mg/ml, aligning closely with the label claim and reflecting a minimal variance of 0.16%.

The breakdown of individual testosterone esters is as follows:

  • Testosterone Propionate: 41.85 mg/ml
  • Testosterone Phenylpropionate: 83.25 mg/ml
  • Testosterone Isocaproate: 83.68 mg/ml
  • Testosterone Decanoate: 141.79 mg/ml

While these results confirm accurate dosing for this batch, it is important to consider potential biases in manufacturer-submitted samples. Independent testing of market-procured products remains essential to ensure batch-to-batch consistency and reliability.


Detailed Report

Product Overview

  • Manufacturer: Noxy Labs
  • Product Name: Sustanon 350 mg/ml
  • Batch Number: 15TMX1
  • Expiration Date: Not provided
  • Delivery Method: Injectable

Sample Acquisition and Testing

  • Task Number: #46707
  • Testing Ordered: 1 August 2024
  • Sample Received: 6 August 2024
  • Analysis Conducted By: Janoshik Analytical
  • Product Submitted By: Noxy Labs (Manufacturer)
  • Analysis Paid For By: Noxy Labs

Testing Results

CompoundMeasured ConcentrationLabel ClaimAccuracyVariance
Testosterone Propionate41.85 mg/ml40 mg/ml104.63%+4.63%
Testosterone Phenylpropionate83.25 mg/ml80 mg/ml104.06%+4.06%
Testosterone Isocaproate83.68 mg/ml80 mg/ml104.60%+4.60%
Testosterone Decanoate141.79 mg/ml150 mg/ml94.53%-5.47%
Total Specification350.57 mg/ml350 mg/ml100.16%+0.16%

The analysis confirms that Sustanon 350 mg/ml contains the intended testosterone esters at accurate concentrations, with a total measured concentration exceeding the label claim by only 0.16%.


Verification Details


Evaluation of Manufacturer-Submitted Testing

This analysis demonstrates that Sustanon 350 mg/ml is accurately formulated, with minimal variance from the label claim. However, since the sample was submitted and funded by the manufacturer, it is crucial to account for potential biases. Manufacturer-submitted samples may not fully represent market-available products. Independent testing of multiple batches from varied sources would provide a more comprehensive evaluation of product reliability and consistency.


Conclusion

The independent analysis of Sustanon 350 mg/ml (batch 15TMX1) confirms a total measured concentration of 350.57 mg/ml, reflecting precise adherence to the labeled specification. This result underscores the accuracy and reliability of this specific batch. Ongoing independent testing is essential to validate product quality and consistency across multiple batches, supporting harm reduction and informed decision-making.


Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases, such as selective sample submissions. The findings pertain solely to the tested batch and may not reflect the entire product line. Cross-referencing these results with independent third-party testing is recommended for a comprehensive evaluation.


Noxy Labs Sustanon Lab Test